Health Benefits Of Pomegranate Flowers
Antioxidants and photochemical reservoirs were present in the pomegranate flowers. They help patients with diabetes in lowering health risks. Not only flowers, seeds and peel can also help in lowering health risks.
A previous study has indicated that the pomegranate flowers along with the diabetes treatment can improve the performance of the brain in patients with diabetes.
Ayurveda and Unani treatments also use the pomegranate flowers for the treatment of diabetes.
Benefits Of Peanut Butter
A previous study has indicated that the peanut butter can lower the risk of obesity and type 2 diabetes (T2D). A study on children has found a lower BMI with the consumption of peanut-based snacks. The researchers say that the peanut-based snacks are healthy alternatives to meat.
A Trial On Drug Victoza (Liraglutide)
A 3-year long LEADER trial on Victoza (liraglutide), manufactured by Novo Nordisk has presented at the 76th scientific sessions of the American Diabetes Association (ADA). The drug Victoza has reduced the blood glucose levels and body weight (weight loss).
The LEADER trial shows a 22 percent reduction in the death due to cardiovascular diseases (CVD), a 22 percent lower risk of kidney disease and a 13 percent lower risk of non-fatal stroke when compared with the placebo arm.
Dr. John Buse, the director of the UNC Diabetes Care Center is the chairman of the LEADER steering Committee. The drug Victoza is commercially available in more than 85 countries for the treatment of type 2 diabetes (T2D).
Update on Aug 8, 2017: The Committee for the Medicinal Products for Human Use (CHMP) panel, which can authorize the medicines in the European Union (EU), has approved the use of drug Victoza (liraglutide) after the LEADER trial.
The CHMP positive opinion has been referred to the European Commission for the approval of the proposed modifications to the label indications on drug Victoza (liraglutide).
The drug Victoza (liraglutide) is the second drug to be recommended for patients with type 2 diabetes (T2D) for the treatment of cardiovascular diseases (CVD).
Jardiance (empagliflozin), a type 2 diabetes (T2D) drug (SGLT2 inhibitor), was the first drug to add the risk reduction of cardiovascular diseases on its label in the European Union.
Benefits Of Jardiance Drug
The EMPA-REG OUTCOME trial was conducted by the lead investigator Dr. Bernard Zinman, director of the Diabetes Center at the Mount Sinai Hospital. The risk of cardiovascular diseases will increase with age for patients with type 2 diabetes.
EMPA-REG OUTCOME trial shows that the Jardiance (empagliflozin) can lower the risk of cardiovascular death and hospitalization from heart failure in all age groups. The trial shows the effectiveness of the Jardiance.
The study was presented in the American Diabetes Association (ADA) 76th Scientific Sessions at New Orleans.
Treatment With Drug Darapladib
Part of the retina in the eye which can read the fine details clearly is called the macula. Swelling of the macula is due to the high levels of sugar (glucose) present in the blood vessels. This is the most common problem in patients with diabetes and about seven percent of patients with diabetes suffer from this problem.
The common treatment for this problem is an injection of a drug directly into the eye for every four to six weeks. This treatment is very expensive and only 50 percent of the patients may get relief.
Professor Alan Stitt (Queen's University) and Dr. Patric Turowski (UCL Institute of Ophthalmology) in collaboration with the GlaxoSmithKline has found that Darapladib (in tablet form) has the potential to lower the vision loss to a wider group of patients with diabetes.
Now, the researchers are planning for a clinical trial with drug darapladib as an alternative treatment to diabetic related blindness.
Benefits Of Vegetarian Diet
The researchers from Harvard University have studied the food habits and the health records of 200,000 people in the United States for the past 20 years. The study shows the following.
The author of the study was Ambika Satija and the co-author of the study was Prof Frank Hu. The study was published in the journal PLoS Medicine and the research was funded by the U.S. National Institutes of Health.
Benefits Of Invokana (Canagliflozin)
A random phase 2 study on diabetes drug Invokana (canagliflozin), manufactured by the Janssen (a subsidiary of Johnson & Johnson), has indicated that invokana can lower the mean glucose levels and glycemic variability in patients of type 1 diabetes (T1D) mellitus.
There is an increase in the amount of time spent within the blood glucose target range. But the study shows an increased risk of ketoacidosis.
The lack of insulin can cause the body to produce excess blood acids and it is known as diabetic ketoacidosis. Ketoacidosis can lead to severe kidney injury. The United States FDA has warned on the risk associated with Invokana.
Benefits Of Mediterranean Diet
A study by Dr. Ramon Estruch, the University of Barcelona has indicated that nuts and olive oil in the Mediterranean diet can prevent the weight gain and may even lower the body weight. The study was published in the Lancet Diabetes and Endocrinology.
A Usability Study On Device Called OneTouch Via Patch
According to the data presented at the American Diabetes Association (ADA) conference in New Orleans, patients with diabetes using OneTouch via patch device have fewer patients missed insulin dosages and felt less stress and embarrassment compared with multiple daily insulin injections.
With the new OneTouch Via patch on demand insulin delivery system, patients with diabetes can take insulin whenever / wherever required by pressing two buttons on the device. The system is a water resistant and can be used for three days.
Benefits Of Weight Loss During Pregnancy
Gestational diabetes (GD) can affect the mother during pregnancy. The born baby can be abnormally large (is macrosomia) with high blood glucose levels. Obesity can amplify the adverse effects of gestational diabetes.
How the health of the born baby will be affected if the obese pregnant women lose body weight during the pregnancy?
The researchers have examined the records of 614 obese pregnant women with gestational diabetes with an average age of 31 years. The study has found a weight loss in 151 women participants and weight gain in 463 women participants. The study shows the following.
The study was presented at the 76th Scientific Sessions of the American Diabetes Association (ADA) at New Orleans, Louisiana.
Partnership Agreement Between Medtronic And Canary Health
Canary Health is a Los Angeles based company. This company is providing chronic health management software.
Now, Canary Health has partnered with Medtronic and Medtronic becomes a reseller and distributor of Canary Health. They are planning to develop additional solutions based on the products of Medtronic and Canary Health.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.